关键信息
-
基因名
nlpD
- 应用
-
别名
nlpD；Murein hydrolase activator NlpD
-
种属
E.coli
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P0ADA3
-
表达区间
26-379aa
-
氨基酸序列
CSDTSNPPAPVSSVNGNAPANTNSGMLITPPPKMGTTSTAQQPQIQPVQQ PQIQATQQPQIQPVQPVAQQPVQMENGRIVYNRQYGNIPKGSYSGSTYTV KKGDTLFYIAWITGNDFRDLAQRNNIQAPYALNVGQTLQVGNASGTPITG GNAITQADAAEQGVVIKPAQNSTVAVASQPTITYSESSGEQSANKMLPNN KPTATTVTAPVTVPTASTTEPTVSSTSTSTPISTWRWPTEGKVIETFGAS EGGNKGIDIAGSKGQAIIATADGRVVYAGNALRGYGNLIIIKHNDDYLSA YAHNDTMLVREQQEVKAGQKIATMGSTGTSSTRLHFEIRYKGKSVNPLRY LPQR
-
分子量
54 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
质检流程
相关产品
背景信息
The research on NLPD recombinant protein stems from the growing interest in understanding and manipulating neurotoxic peptides for therapeutic purposes. NLPD, a neurotoxin derived from certain venomous organisms, has garnered attention due to its unique structure and potent biological activity. These peptides have the potential for applications in drug development, particularly in treating neurological disorders or as tools for molecular biology. Researchers are focused on recombinant technology to produce NLPD with high purity and yield, which allows for detailed structural and functional studies. This approach not only enables the exploration of NLPD's mechanisms of action but also aids in the identification of potential analogs with improved therapeutic profiles. Additionally, studying NLPD in the context of protein engineering could lead to innovations in biomedicine, enhancing our ability to design targeted interventions for a variety of diseases. The integration of bioinformatics and molecular modeling in this research further contributes to the understanding of NLPD's interactions at the molecular level, paving the way for developing new classes of pharmaceuticals. Overall, the NLPD recombinant protein serves as a promising candidate for advancing both basic research and clinical applications in neuropharmacology.
